MedGenome Becomes First Genomics Firm in South-East Asia to Acquire High Throughput Illumina Hiseq X Ten Platform
BANGALORE and FOSTER CITY, California —
MedGenome today announced that it has purchased the Illumina Hiseq X Ten platform to fuel its genomic research services capability and capacity. MedGenome joins a small number of global players in the genomics research space, and the first one in South-East Asia, to own one of these high throughput Illumina sequencing platforms.
“We are passionate about improving human health through use of genomics research and insights,” said Mr. Sam Santhosh, Chairman and Global CEO, MedGenome.” We will have these machines operational in India and the US by next month and will be looking forward to collaborating with various large-scale genomic projects in the region and abroad.”
With its high throughput and unprecedented low price per genome, the HiSeq X Ten makes population-scale whole-genome sequencing (WGS) an affordable reality. The technology is bringing down the price of Whole Genome and Whole Genome Methylation sequencing to one-third of the current c

